A Mycobacterium marinum zone of inhibition assay as a method for screening potential antimycobacterial compounds from marine extracts

Planta Medica

Volumn 73, Issue 6, 2007, Pages 559-563

  Barker, Lucia P ^a   Lien, Benjamin A ^b   Brun, Olivier S ^a   Schaak, Damen D ^c   McDonough, Kathleen A ^c   Leng, Chee Chang ^b,d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA DULUTH   (United States)

^c WADSWORTH CENTER   (United States)

^d UNIVERSITY OF HAWAII AT HILO   (United States)

Author keywords

( ) papuamine; Antimycobacterial; Haliclona sp. 10; Mycobacterium marinum

Indexed keywords

ANTIMYCOBACTERIAL AGENT; NATURAL PRODUCT; PAPUAMINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CHEMICAL STRUCTURE; DRUG SCREENING; GROWTH INHIBITION; HALICLONA; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SPECIES COMPARISON;

ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM MARINUM; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; REPRODUCIBILITY OF RESULTS; SEAWATER;

HALICLONA SP.; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 34250884055     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981522     Document Type: Article

References (31)

1. Gbayisomore A, Lardisabal AA, Reichman LB. Update: prevention and treatment of tuberculosis. Curr Opin Infect Dis 2000; 13: 155-9.
2. Dye C, Williams BG, Espinal MA, Raviglione MC. Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science 2002; 295: 2042-6.
3. Aubry A, Jarlier V, Escolano S, Truffot-Pernot C, Cambau E. Antibiotic susceptibility pattern of Mycobacterium marinum. Antimicrob Agents Chemother 2000; 44: 3133-6.
4. Centers for Disease Control and Prevention Emergence of Mycobacterium tuberculosis with extensive resistance to sSecond-line drugs - worldwide, 2000-2004. MMWR; 2006; 55: 301-5.
5. Fusetani N, Yasumuro K, Matsunaga S, Hirota H. Haliclamines A and B, cytotoxic macrocyclic alkaloids from a sSponge of the genus Haliclona. Tetrahedron Lett 1989; 30: 6891-4.
6. Falch BS, König GM, Wright AD, Sticher O. Ambigol A and B; new biologically active polychlorinated aromatic compounds from the terrestrial blue-green alga Fischerella ambigua. J Org Chem 1993; 58: 6570-5.
7. Donia M, Hamann MT. Marine natural products and their potential applications as anti-infective agents. Lancet Infect Dis 2003; 3: 338-48.
8. Rogall T, Wolters J, Flohr T, Bottger EC. Towards a phylogeny and definition of species at the molecular level within the genus Mycobacterium. Int J Syst Bacteriol 1990; 40: 323-30.
9. Tonjum T, Welty DB, Jantzen E, Small PLC. Differentiation of Mycobacterium ulcerans, M. marinum and M. haemophilum: mapping of their relationships to M. tuberculosis by fatty acid profile analysis, DNA-DNA hybridization and 16S rRNA gene sequence analysis. J Clin Microbiol 1998; 36: 918-25.
10. Stamm LM, Brown EJ. Mycobacterium marinum: the generalization and specialization of a pathogenic mycobacterium. Microbes Infect 2004; 6: 1418-28.
11. Kaattari IM, Rhodes MW, Kaattari SL, Shotts EB. The evolving story of Mycobacterium tuberculosis clade members detected in fish. J Fish Dis 2006; 29: 509-20.
12. Barker LP, George KM, Falkow S, Small PLC. Differential trafficking of live and dead Mycobacterium marinum organisms in macrophages. Infect Immunol 1997; 65: 1497-504.
13. Werngren J, Olsson-Liljequist B, Gezelius L, Hoffner SE. Antimicrobial susceptibility of Mycobacterium marinum determined by E-test and agar dilution. Scand J Infect Dis 2001; 33: 585-8.
14. Pagan-Ramos E, Song J, McFalone M, Mudd MH, Deretic V. Oxidative stress response and characterization of the oxyR-ahpC and furA-katG loci in Mycobacterium marinum. J Bacteriol 1998; 180: 4856-64.
15. Somoskovi A, Parsons LM, Salfinger M. The molecular basis of resistance to isoniazid, rifampin and pyrazinamide in Mycobacterium tuberculosis. Respir Res 2001; 2: 164-8.
16. Pagan-Ramos E, Master SS, Pritchett CL, Reimschuessel R, Trucksis M, Timmins GS et al. Molecular and physiological effects of mycobacterial oxyR inactivation. J Bacteriol 2006; 188: 2674-80.
17. Discotere A, Hermans K, Haesebrouck F. Piscine mycobacteriosis: a literature review covering the agent and the disease it causes in fish and humans. Vet Microbiol 2004; 99: 159-66.
18. Sakai R, Kohmoto S, Higa T, Jefford CW, Bernardinelli G. Manzamine B and C, alkaloids from sponge Haliclona sp. Tetrahedron Lett 1987; 28: 5493-6.
19. Kobayashi M, Chen YJ, Aoki S, In Y, Ishida T, Kitagawa I. Four new beta-carboline alkaloids isolated from two Okinawan marine sponges of Xestospongia sp. and Haliclona sp. Tetrahedron 1995; 51: 3727-36.
20. Worthington M, Luo RQ, Pelo J. Copacabana method for spreading E. coli and yeast colonies. BioTechniques 2001; 30: 738-42.
21. Baker BJ, Scheuer PJ, Schoolery JN. Papuamine and antifungal pentacyclic alkaloid from a marine sponge, Haliclona sp. J Am Chem Soc 1988; 110: 965-6.
22. MARINLIT. A marine literature database maintained by the Marine Chemistry Group, University of Canterbury. Christchurch, New Zealand: 2002.
23. Sakai R, Higa T, Jefford CW, Bernardinelli G. Manzamine A, a novel antitumor alkaloid from a sponge. J Am Chem Soc 1986; 108: 6404-5.
24. Yousat M, El Sayed KA, Rao KV, Lim CW, Hu J, Kelly M et al. 12,34-Oxamanzamines, novel biocatalytic and natural products from manzamine producting indo-paccific sponges. Tetrahedron 2002; 58: 7397-402.
25. Clark RJ, Field KL, Charan RD, Garson MJ, Brereton IM, Willis AC. The haliclonacyclamines, cytotoxic tertiary alkaloids from the tropical marine sponge Haliclona sp. Tetrahedron 1998; 54: 8811-26.
26. Fahy E, Molinski TF, Harper MK, Sullivan BW, Faulkner DJ. Haliclonadiamine, an antimicrobial alkaloid from the sponge Haliclona sp. Tetrahedron Lett 1988; 29: 3427-8.
27. Borzilleri RM, Weinreb SM, Parvez M. Total synthesis of the unusual marine alkaloid (-)-papuamine utilizing a novel imino ene reaction. J Am Chem Soc 1995; 117: 10 905-13.
28. Heifets L, Lindholm-Levy P. Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis. Antimicrob Agents Chemother 1989; 33: 1298-301.
29. Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A et al. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate alamar blue assay. J Clin Microbiol 1998; 36: 362-6.
30. Xu Z, Barrow WW, Suling WJ, Westbrook L, Barrow E, Lin Y et al. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis. Bioorg Med Chem 2004; 12: 1199-207.
31. Edrada RA, Proksch P, Wray V, Witte L, Müller WEG, Soest RWM. Four new bioactive manzamine-type alkaloids from the Philippine marine sponge Xestospongia ashmorica. J. Nat Prod 1996; 59: 1056-60.